Creative Planning
TARS icon

Creative Planning’s Tarsus Pharmaceuticals TARS Stock Holding History

Creative Planning’s Portfolio TARS Stock Details TARS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$816K Sell
12,972
-1,420
-10% -$90.7K ﹤0.01% 2814
2026
Q1 		$1.01M Buy
14,392
+366
+3% +$25.6K ﹤0.01% 2446
2025
Q4 		$1.15M Buy
14,026
+1,659
+13% +$124K ﹤0.01% 2174
2025
Q3 		$735K Buy
12,367
+393
+3% +$19.3K ﹤0.01% 2397
2025
Q2 		$485K Sell
11,974
-2,329
-16% -$105K ﹤0.01% 2494
2025
Q1 		$735K Buy
14,303
+1,126
+9% +$55.7K ﹤0.01% 1972
2024
Q4 		$730K Buy
13,177
+2,175
+20% +$98.8K ﹤0.01% 1896
2024
Q3 		$362K Buy
+11,002
New +$309K ﹤0.01% 2371
2024
Q2 		– Sell
-6,595
Closed -$240K – 3168
2024
Q1 		$240K Buy
+6,595
New +$194K ﹤0.01% 2434

Other funds holding TARS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Creative Planning's TARS Position: Q2 2026 in Review

Creative Planning reduced its Tarsus Pharmaceuticals (TARS) stake by 9.9% in Q2 2026, selling an estimated $90.7K and leaving 12,972 shares worth $816K. The position accounts for ﹤0.01% of the portfolio, ranked #2814.

Creative Planning first reported a position in TARS in Q1 2024 and has held it in 9 quarters since. The position peaked at $1.15M in Q4 2025. 257 funds tracked by Wall St. Rank hold TARS as of Q2 2026.

  • Creative Planning held 12,972 shares of Tarsus Pharmaceuticals worth $816K as of Q2 2026.
  • Creative Planning sold 1,420 Tarsus Pharmaceuticals shares in Q2 2026, an estimated $90.7K.
  • Tarsus Pharmaceuticals made up ﹤0.01% of Creative Planning's portfolio in Q2 2026, its #2814 holding.
  • Creative Planning first reported a position in Tarsus Pharmaceuticals in Q1 2024 and has held it in 9 quarters since.
  • Creative Planning's Tarsus Pharmaceuticals position peaked at $1.15M in Q4 2025.
  • 257 funds tracked by Wall St. Rank held Tarsus Pharmaceuticals as of Q2 2026.

Based on Creative Planning's 13F filing for Q2 2026, filed 13 Aug 2026.